Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)
- Author
- BALLANTYNE, Christie M1 ; WEISS, Robert2 ; MOCCETTI, Tiziano3 ; VOGT, Anja4 ; EBER, Bernd5 ; SOSEF, Froukje6 ; DUFFIELD, Emma6
[1] Methodist DeBakey Heart Center and Baylor College of Medicine, Houston, Texas, United States
[2] Androscoggin Cardiology Research, Auburn, Maine, United States
[3] Cardiocentro Ticino, Lugano, Switzerland
[4] Charité Berlin, Berlin, Germany
[5] Klinikum Kreuzschwestern Wels, Wels, Austria
[6] AstraZeneca, Macclesfield, United Kingdom
EXPLORER Study Investigators - Source
The American journal of cardiology. 2007, Vol 99, Num 5, pp 673-680, 8 p ; ref : 25 ref
- CODEN
- AJCDAG
- ISSN
- 0002-9149
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Appareil circulatoire pathologie Appareil circulatoire Cardiologie Complication Efficacité Ezétimibe Haut Phlébologie Rosuvastatine Résultat Sécurité Toxicité Groupe à risque
- Keyword (en)
- Cardiovascular disease Circulatory system Cardiology Complication Efficiency Ezetimibe High Phlebology Rosuvastatin Result Safety Toxicity
- Keyword (es)
- Aparato circulatorio patología Aparato circulatorio Cardiología Complicación Eficacia Ezetimiba Alto Flebología Rosuvastatina Resultado Seguridad Toxicidad
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18916126
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.amjcard.2006.10.022 
https://dx.doi.org/10.1016/j.amjcard.2006.10.022
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.amjcard.2006.10.022\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of cardiology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Am. j. cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"673\";s:8:\"\u0000*\u0000epage\";s:3:\"680\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALLANTYNE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Christie M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"WEISS, Robert\";i:1;s:17:\"MOCCETTI, Tiziano\";i:2;s:10:\"VOGT, Anja\";i:3;s:11:\"EBER, Bernd\";i:4;s:14:\"SOSEF, Froukje\";i:5;s:14:\"DUFFIELD, Emma\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCDAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.amjcard.2006.10.022\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of cardiology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Am. j. cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"673\";s:8:\"\u0000*\u0000epage\";s:3:\"680\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALLANTYNE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Christie M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"WEISS, Robert\";i:1;s:17:\"MOCCETTI, Tiziano\";i:2;s:10:\"VOGT, Anja\";i:3;s:11:\"EBER, Bernd\";i:4;s:14:\"SOSEF, Froukje\";i:5;s:14:\"DUFFIELD, Emma\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCDAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.amjcard.2006.10.022\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.amjcard.2006.10.022\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of cardiology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Am. j. cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"673\";s:8:\"\u0000*\u0000epage\";s:3:\"680\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALLANTYNE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Christie M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"WEISS, Robert\";i:1;s:17:\"MOCCETTI, Tiziano\";i:2;s:10:\"VOGT, Anja\";i:3;s:11:\"EBER, Bernd\";i:4;s:14:\"SOSEF, Froukje\";i:5;s:14:\"DUFFIELD, Emma\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCDAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.amjcard.2006.10.022\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of cardiology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Am. j. cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"673\";s:8:\"\u0000*\u0000epage\";s:3:\"680\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALLANTYNE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Christie M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"WEISS, Robert\";i:1;s:17:\"MOCCETTI, Tiziano\";i:2;s:10:\"VOGT, Anja\";i:3;s:11:\"EBER, Bernd\";i:4;s:14:\"SOSEF, Froukje\";i:5;s:14:\"DUFFIELD, Emma\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCDAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/j.amjcard.2006.10.022\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The American journal of cardiology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Am. j. cardiol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"99\";s:8:\"\u0000*\u0000issue\";s:1:\"5\";s:8:\"\u0000*\u0000spage\";s:3:\"673\";s:8:\"\u0000*\u0000epage\";s:3:\"680\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-9149\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:10:\"BALLANTYNE\";s:10:\"\u0000*\u0000aufirst\";s:10:\"Christie M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:13:\"WEISS, Robert\";i:1;s:17:\"MOCCETTI, Tiziano\";i:2;s:10:\"VOGT, Anja\";i:3;s:11:\"EBER, Bernd\";i:4;s:14:\"SOSEF, Froukje\";i:5;s:14:\"DUFFIELD, Emma\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AJCDAG\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:165:\"Efficacy and safety of Rosuvastatin 40 mg alone or in combination with Ezetimibe in patients at high risk of cardiovascular disease (Results from the EXPLORER Study)\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
